We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Seeks Feedback to Guideline on Biosimilar Similarity Rules
EMA Seeks Feedback to Guideline on Biosimilar Similarity Rules
June 12, 2013
The European Medicines Agency (EMA) has issued revisions to a 2006 biosimilar guideline, which clarify clinical and nonclinical requirements for marketing such products.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor